Health
ESMO experts: Do not discontinue or delay cancer treatment impacting on overall survival. – Brinkwire
An ESMO interdisciplinary expert consensus paper on how to manage cancer patients during the COVID-19 pandemic has been published today in Annals of Oncology, encouraging medical oncologists worldwide not to discontinue or delay any type of anti-cancer treatment that may potentially impact on overall survival. The experts also urge to stop labelling all cancer patients as vulnerable to coronavirus infection since this may lead to inappropriate care and potential negative outcomes.
Coronavirus d…
-
General22 hours agoMourners arrive for Diogo Jota’s wake in Liverpool forward’s hometown in Portugal
-
Business21 hours ago3 ASX growth shares to buy before the next bull market
-
General8 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
General21 hours agoDear God! It’s 2028 | The Spectator Australia